Phase I Study of an Oncofetal Antigen Multi-Peptide Immunotherapy in Subjects With Hematologic Cancer
- First Posted Date
- 2014-09-15
- Last Posted Date
- 2016-04-19
- Lead Sponsor
- Benovus Bio, Inc.
- Target Recruit Count
- 4
- Registration Number
- NCT02240537
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸University of Michigan, Ann Arbor, Michigan, United States
🇺🇸Virginia Cancer Specialists, Fairfax, Virginia, United States
© Copyright 2024. All Rights Reserved by MedPath